Evidence
World J Gastroenterol. 2024 Aug 21;30(31):3635-3639. doi: 10.3748/wjg.v30.i31.3635.
ABSTRACT
Post-embolization syndrome (PES) is the most common complication in patients with hepatocellular carcinoma treated with transarterial chemoembolization. Many strategies have been evaluated to reduce the incidence of PES, but no standard prevention guidelines currently exist. In a single-center, placebo-controlled trial, Simasingha et al evaluated the prophylactic administration of a combination of dexamethasone and N-acetylcysteine and documented a significant reduction in the incidence of PES (from 80% to 6%), of post-procedural liver decompensation (from 14% to 0%), and a shorter hospital stay (4 days vs 6 days), alongside an acceptable safety profile. The results of this study raise several controversial points regarding their applicability in the Western world. In the West, there is a greater and increasing prevalence of metabolic and alcoholic etiologies of liver cirrhosis, so a not negligible number of patients with type II diabetes or hypertension would be excluded from high-dosage dexamethasone prophylaxis. Furthermore, in the West, there is a preferred use of drug-eluting beads loaded with doxorubicin, which are associated with a lower incidence of PES. A study on prophylaxis with dexamethasone and/or N-acetylcysteine in a Western population is hopefully awaited.
PMID:39193004 | PMC:PMC11346156 | DOI:10.3748/wjg.v30.i31.3635
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Dexamethasone and N-acetylcysteine before transarterial chemoembolization in hepatocellular carcinoma: A Western perspective
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma
- Scale offers the possibility of identifying adherence to lifestyle interventions in patients with non-alcoholic fatty liver disease
- Metabolic dysfunction-associated fatty liver disease and low muscle strength: A comment
- Effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease: Clinical implications
- The effect of dexamethasone on the incidence of delirium in patients hospitalized due COVID-19 infection: a retrospective cohort study
- Effective roles of exercise and diet adherence in non-alcoholic fatty liver disease
- Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease
- Variceal bleeding following treatment with atezolizumab plus bevacizumab in two patients with unresectable hepatocellular carcinoma
- Quantitative assessment of self-management in patients with non-alcoholic fatty liver disease: An unmet clinical need
- Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease
- Targeted metabolomics study of fatty-acid metabolism in lean metabolic-associated fatty liver disease patients
- Adolescent Psychotic Experiences and Adverse Mental Health Outcomes in Adulthood in a General Population Sample
- Validation of adherence prediction system for lifestyle interventions in nonalcoholic fatty liver disease
- Police-referred psychiatric emergency presentations during the first and second wave of COVID-19 in Berlin, Germany: a retrospective chart review
- Integrated analysis of single-cell and bulk RNA sequencing data reveals a cellular senescence-related signature in hepatocellular carcinoma
- Temporal trends and long-term outcomes of radiofrequency ablation for hepatocellular carcinoma within the Milan criteria
- Trends in Hospital Stay, Complication Rate, and Mortality in Hip Fracture Patients: A Two-Decade Comparison at a National Tertiary Referral Center
- A male mouse model for metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma
- Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation
- Impact of multiple primary cancers on overall survival of patients with hepatocellular carcinoma
- Relation between ARFID symptomatology and picky eating onset and duration
- MAFLD in adults: non-invasive tests for diagnosis and monitoring of MAFLD
- Evaluation of postoperative delirium in geriatric patients given acetaminophen with and without melatonin: A retrospective cohort study
- Lower hepatocellular carcinoma surveillance in metabolic dysfunction-associated steatotic liver disease: Impact on treatment eligibility
- Lower hepatocellular carcinoma surveillance in metabolic dysfunction-associated steatotic liver disease: Impact on treatment eligibility
- Periodontitis promotes hepatocellular carcinoma in Stelic Animal model (STAM) mice
- Efficacy and Safety of a Self-Improved Continuous Bladder Irrigation Sensor Device in Patients after Transurethral Resection of the Prostate: A Prospective Study
- Efficacy and Safety of a Self-Improved Continuous Bladder Irrigation Sensor Device in Patients after Transurethral Resection of the Prostate: A Prospective Study
- The Role of Extrahepatic Features on the Development and Management of Hepatocellular Carcinoma in Steatotic Liver Disease
- The Role of Extrahepatic Features on the Development and Management of Hepatocellular Carcinoma in Steatotic Liver Disease
- Impact of inhaled sedation on delirium incidence and neurological outcome after cardiac arrest - a propensity-matched control study (Isocare)
- The role and mechanism of SUMO modification in liver disease
- A retrospective analysis of the incidence and risk factors of perioperative urinary tract infections after total hysterectomy
- Exercise-activated hepatic autophagy combined with silymarin is associated with suppression of apoptosis in rats subjected to dexamethasone induced- fatty liver damage
- Exercise-activated hepatic autophagy combined with silymarin is associated with suppression of apoptosis in rats subjected to dexamethasone induced- fatty liver damage
- A Case Presentation of Well-Differentiated Hepatocellular Carcinoma With No Sign of Liver Disease
- Effect of mannitol on postoperative delirium in patients undergoing coronary artery bypass graft: a randomised controlled trial
- EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
- The Role of CD4+T Cells in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
- Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) data from 2004 to 2023
- Small nucleolar RNA expression profiles: A potential prognostic biomarker for non-viral Hepatocellular carcinoma
- Liquidambaric acid inhibits the proliferation of hepatocellular carcinoma cells by targeting PPARα-RXRα to down-regulate fatty acid metabolism
- Impact of the COVID-19 pandemic on care-quality outcomes in older adults admitted to hospital with altered mental status
- Nonadherence to oral cancer chemotherapy in hepatocellular carcinoma: prevalence and predictive factors in Vietnam
- Impact of an alcohol withdrawal screening and treatment protocol for hospitalized patients
- Electroencephalography-Guided Anesthesia and Delirium in Older Adults After Cardiac Surgery: The ENGAGES-Canada Randomized Clinical Trial
- Effect of the nurse-led Hospital Elder Life Program on delirium reduction among delirious patients with COVID-19: A randomized clinical trial
- Crosstalk between Epigenetics and Metabolic Reprogramming in Metabolic Dysfunction-Associated Steatotic Liver Disease-Induced Hepatocellular Carcinoma: A New Sight
- Recurrence of Primary Disease After Adult Liver Transplant - Risk Factors, Early Diagnosis, Management, and Prevention
- Blood magnesium level and risk of hepatocellular carcinoma in a prospective liver cirrhosis cohort
- Impact of Perioperative Empathic Care on Postoperative Psychological Status in Patients with Cervical Cancer
- Proton-beam Therapy for Locally Advanced Hepatocellular Carcinoma With Inferior Vena Cava Tumor Thrombus: Case Report
- Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives
- Development of an Optimized Promoter System for Exosomal and Naked AAV Vector-Based Suicide Gene Therapy in Hepatocellular Carcinoma
- Effectiveness of a delirium risk assessment and multidisciplinary care approach in reducing delirium incidence among surgical intensive care unit patients: A retrospective pre-post intervention study
- Serum Vascular Adhesion Protein-1 and Endothelial Dysfunction in Hepatic Cirrhosis: Searching for New Prognostic Markers
- Association Between Pupil Light Reflex and Delirium in Adults With Traumatic Brain Injury: Preliminary Findings
- Nutraceuticals and phytoceuticals in the treatment of schizophrenia: a systematic review and network meta-analysis "Nutra NMA SCZ"
- Efficacy of GnRH Pulses in Hypogonadism Secondary to Primary Empty Sella: Case Report
- Efficacy of GnRH Pulses in Hypogonadism Secondary to Primary Empty Sella: Case Report
- Effects of Marine Natural Products on Liver Diseases
- Alcohol rehabilitation and cancer risk: a nationwide hospital cohort study in France
- Effects of Intranasal Insulin Pretreatment on Preoperative Sleep Quality and Postoperative Delirium in Patients Undergoing Valve Replacement for Rheumatic Heart Disease
- Safety and tolerability of esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression
Evidence Blueprint
Dexamethasone and N-acetylcysteine before transarterial chemoembolization in hepatocellular carcinoma: A Western perspective
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Dexamethasone and N-acetylcysteine before transarterial chemoembolization in hepatocellular carcinoma: A Western perspective
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Hepatocellular Carcinoma in Ceará: Epidemiology and Treatment in a Reference Liver Transplant Center in Northeast Brazil
- Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease
- Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease
- Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma
- Interplay between metabolic dysfunction-associated fatty liver disease and renal function: An intriguing pediatric perspective
- Scale offers the possibility of identifying adherence to lifestyle interventions in patients with non-alcoholic fatty liver disease
- Metabolic dysfunction-associated fatty liver disease and low muscle strength: A comment
- Liver decompensation after rapid weight loss from semaglutide in a patient with non-alcoholic steatohepatitis -associated cirrhosis
- Effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease: Clinical implications
- The effect of dexamethasone on the incidence of delirium in patients hospitalized due COVID-19 infection: a retrospective cohort study
- Effective roles of exercise and diet adherence in non-alcoholic fatty liver disease
- Portal hypertension in patients with nonalcoholic fatty liver disease: Current knowledge and challenges
- Fecal microbiota transplantation for treatment of non-alcoholic fatty liver disease: Mechanism, clinical evidence, and prospect
- Predicting Survival Using Whole-Liver MRI Radiomics in Patients with Hepatocellular Carcinoma After TACE Refractoriness
- Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease
- Variceal bleeding following treatment with atezolizumab plus bevacizumab in two patients with unresectable hepatocellular carcinoma
- The temporal association between social isolation, distress, and psychotic experiences in individuals at clinical high-risk for psychosis
- Longitudinal trajectories of plasma polyunsaturated fatty acids and associations with psychosis-spectrum outcomes in early adulthood
- Longitudinal trajectories of plasma polyunsaturated fatty acids and associations with psychosis-spectrum outcomes in early adulthood
- Quantitative assessment of self-management in patients with non-alcoholic fatty liver disease: An unmet clinical need
- The Psychological Emptiness Scale: a psychometric evaluation
- Transarterial Embolization for Cystic Artery Pseudoaneurysm Caused by Hepatocellular Carcinoma Rupture in the Gallbladder: A Case Report
- Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease
- Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease
- Novel subtype of obesity influencing the outcomes of sleeve gastrectomy: Familial aggregation of obesity
- Examining psychotic experiences in two generations - findings from a rural household-based cohort study; the Lolland-Falster Health Study
- Post-error adjustments occur in both reaching and grasping
- Phytochemicals as Potential Lead Molecules against Hepatocellular Carcinoma
- Targeted metabolomics study of fatty-acid metabolism in lean metabolic-associated fatty liver disease patients
- A Review of Incidence and Related Risk Factors in the Development of Hepatocellular Carcinoma
- Adolescent Psychotic Experiences and Adverse Mental Health Outcomes in Adulthood in a General Population Sample
- Association between tuberculosis and psychotic experiences: Mediating factors and implications for patient care in low- and middle-income countries
- Analysis of genetic factors associated with fatty liver disease-related hepatocellular carcinoma
- Validation of adherence prediction system for lifestyle interventions in nonalcoholic fatty liver disease
- The impact of cumulative obstetric complications and childhood trauma on brain volume in young people with psychotic experiences
- Efficacy of Yttrium-90 Transarterial Radioembolisation in Advanced Hepatocellular Carcinoma: An Experience With Hybrid Angio-Computed Tomography and Glass Microspheres
- Insulin Use and The Risk of Hepatocellular Carcinoma: Insights and Implications
- Application and challenge of pathomics technique in the management of hepatocellular carcinoma
- Reduced neural encoding of utility prediction errors in cocaine addiction
- Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity
- Depression is associated with blunted affective responses to naturalistic reward prediction errors
- Police-referred psychiatric emergency presentations during the first and second wave of COVID-19 in Berlin, Germany: a retrospective chart review
- Association of GLP-1 receptor agonists and hepatocellular carcinoma incidence and hepatic decompensation in patients with type 2 diabetes
- Integrated analysis of single-cell and bulk RNA sequencing data reveals a cellular senescence-related signature in hepatocellular carcinoma
- Temporal trends and long-term outcomes of radiofrequency ablation for hepatocellular carcinoma within the Milan criteria
- Challenges and Solutions in the Management of Hepatocellular Carcinoma Associated with Non-Alcoholic Fatty Liver Disease
- Impact of the diagnosis of metabolic dysfunction-associated fatty liver disease and non-alcoholic fatty liver disease in patients undergoing liver transplantation for hepatocellular carcinoma
- New Opportunities in the Systemic Treatment of Hepatocellular Carcinoma-Today and Tomorrow
- Efficacy and safety of semaglutide in non-alcoholic fatty liver disease
- Screening embryos for polygenic disease risk: a review of epidemiological, clinical, and ethical considerations
- Spatial Heterogeneity of Brain Lipids in SIV-Infected Macaques Treated with Antiretroviral Therapy
- Trends in Hospital Stay, Complication Rate, and Mortality in Hip Fracture Patients: A Two-Decade Comparison at a National Tertiary Referral Center
- The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH
- Evaluation of the effects of pregabalin and dexamethasone coadministration on preemptive multimodal analgesia and anxiety in third molar surgeries: a triple-blind randomized clinical trial
- Evaluation of the effects of pregabalin and dexamethasone coadministration on preemptive multimodal analgesia and anxiety in third molar surgeries: a triple-blind randomized clinical trial
- Trajectories of Adolescent Media Use and Their Associations With Psychotic Experiences
- A male mouse model for metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma
- Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments
- p53R245W mutation fuels cancer initiation and metastases in NASH-driven liver tumorigenesis
- Ethnoracial Risk Variation Across the Psychosis Continuum in the US: A Systematic Review and Meta-Analysis
- The relationship between climate change anxiety and psychotic experiences is mediated by death anxiety
- Exploration of PCL-5 symptom validity indices for detection of exaggerated and feigned PTSD
- Stemness markers in hepatocellular carcinoma of Eastern vs. Western population: Etiology matters?
- Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation